Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa Read more about Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa
Phase 2 Trial of MRTX849 Monotherapy and in Combination With Pembrolizumab for NSCLC With KRAS G12C Mutation KRYSTAL-7 Read more about Phase 2 Trial of MRTX849 Monotherapy and in Combination With Pembrolizumab for NSCLC With KRAS G12C Mutation KRYSTAL-7
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, ALCHEMIST Chemo-IO Study Read more about Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, ALCHEMIST Chemo-IO Study
Registry of Asthma Patients Initiating DUPIXENT® Read more about Registry of Asthma Patients Initiating DUPIXENT®
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer Read more about Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors Read more about Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
ACTIV-3: Therapeutics for Inpatients With COVID-19 Read more about ACTIV-3: Therapeutics for Inpatients With COVID-19
Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE Read more about Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV Read more about Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults Read more about Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults